Vioxx Deal To Affect Other Merck Litigation: Experts

Law360, New York (November 9, 2007, 12:00 AM EST) -- Though Friday's $4.85 billion settlement may bring an end to the bulk of the product liability litigation filed against Merck & Co. Inc. over painkiller Vioxx, the company remains entangled in several lawsuits related to the blockbuster drug. While the massive payment will not settle these cases, it may have an effect on how they play out.

In a settlement made public on Nov. 9, Merck agreed to pay $4.85 billion into a settlement fund that will be distributed to product liability plaintiffs on a case-by-case...
To view the full article, register now.